Title:
ハーダー腺分泌物に見出される化合物で眼疾患を治療する方法
Document Type and Number:
Japanese Patent JP6739419
Kind Code:
B2
Abstract:
The present invention is directed to pharmaceutical compositions comprising compounds found in Harderian gland secretions, a method of treating dry eye in a human comprising ophthalmically administering an effective amount of a compound, e.g. a lipid compound, found in Harderian gland secretions, pharmaceutical compositions comprising said lipid compounds, as identified by characteristic chemical data and mass spectra of said lipid compounds, said lipid compound in essentially pure form, and an ophthalmic vehicle comprising a therapeutic agent and a compound present in the secretions of the Harderian gland, e.g. a lipid compound, found in the secretions of the Harderian gland, e.g. a rabbit Harderian gland.
More Like This:
Inventors:
Albert, Daniel M.
Polance, Arthur S.
Polance, Arthur S.
Application Number:
JP2017222773A
Publication Date:
August 12, 2020
Filing Date:
November 20, 2017
Export Citation:
Assignee:
Lester Tears, LRC
International Classes:
A61K31/22; A61K45/00; A61P27/04
Domestic Patent References:
JP2012504639A |
Foreign References:
US4595681 | ||||
US7223737 |
Other References:
Biotechnology Letters,1997年,19(9),p.853-855
Attorney, Agent or Firm:
Harakenzo world patent & trademark